Advances in the treatment of Crohn's disease and ulcerative

When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), reducing the need for steroids and risk of hospitalization.

Dr. Edward V. Loftus, MD, Rochester, MN, Gastroenterologist

VMS BioMarketing on LinkedIn: UCB's Bimekizumab is Now Available

Satellite Symposia - DDW

specialized ibd, SAVE 16%

Understanding the clinical significance of disease detected by imaging but not by ileoscopy or biopsy - Mayo Clinic

NEPC20 AGENDA – Connecticut Pharmacists Association

Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

Digestive Diseases News - Medical Professionals - Mayo Clinic

Digestive Diseases News - Medical Professionals - Mayo Clinic

Are Biologics Right for You?

Novel stem cell therapy for perianal fistula in pediatric patients with Crohn's disease - Mayo Clinic

NEPC20 AGENDA – Connecticut Pharmacists Association

NEPC20 AGENDA – Connecticut Pharmacists Association